Promoting collaboration & capacity building for EVidence-Based Research. An EU-funded COST Action CA-17117. Tweets by @CarolineBlaine (en) & @EBaladia (es)
EVBRES COST Action CA-17117 ended on 16th April 2023. We are very grateful to everyone who helped us achieve so much over the 4.5 years of the action and are pleased that this work will continue as part of the EBRNetwork. Please follow @ebrnetwork for all the latest on EBR
EVBRES COST Action CA-17117 ended on 16th April 2023. We are very grateful to everyone who helped us achieve so much over the 4.5 years of the action and are pleased that this work will continue as part of the EBRNetwork. Please follow @ebrnetwork for all the latest on EBR
Our new article in Systematic Reviews journal: Definition, harms, and prevention of redundant systematic reviews. Thanks to @tweethlund for co-authoring within the COST @evbres action @ebrnetwork@COSTprogramme#evidencebasedresearch
Read the paper here: https://t.co/6d3lX1aGu3
In this lovely new article of ours (Definition, harms, and prevention of redundant systematic reviews) you can also read how to kill a zombie. 😀@tweethlund @evbres@ebrnetwork@COSTprogramme#evidencebasedresearch
Link to the article:
https://t.co/6d3lX1aGu3
Settling down for the afternoon with a ☕️ to listen to @evbres, a COST Action network advocating the use of an Evidence-Based Research (EBR) approach in clinical research. Great peer-to-peer exchange happening between #COSTactions at @COST_Academy today.
We're live with the COST Action webinar series learning more about evidence-based research and why it's important when justifying new studies. Big thank you to @evbres for presenting your work on the problem of redundant research and the concept of evidence-based research. 👏
This is why we advocate an Evidence-Based Research Approach to justifying and designing new studies
https://t.co/YGHLzAzJwc
https://t.co/364IBxRQ3Y (open access)
It is hard not to look at a forest plot like this and not feel like the entire exercise of science has failed here
Decades of tiny, useless trials instead of a handful of big, useful ones
@COST_Academy webinar on Evidence-Based Research presented by @evbres
📅Thursday 30 March, 15:00-16:00 CET
Registration link open until today: https://t.co/y0Q1O5eFFd
Password: WEBMARCH2023
Publication from the @evbres , we conducted a #Delphi Study to dentify the most promising areas and methods to improve #SystematicReviews production and updating.
More info: https://t.co/252elAKyT1
"Decision makers often rely on de novo SRs instead of using existing SRs...All cases have in common that unintended duplication of research occurred between health authorities and academia, demonstrating a lack of communication and coordination between them."
Working group 4 of the COST EVBRES action is meeting in Zagreb, Croatia. The group is working on methods for EBR monitoring implementation and core outcomes for citation analysis. @evbres@COSTprogramme#ebr
Today we are having the last online meeting for all participants in @evbres - a chance to review all we have achieved over the last 4 years and 4 months and to plan for the last month of the Action